A Randomised Trial Comparing Drug Coated Balloons and Conventional Balloons for the Treatment of Stent Graft Stenosis in Dialysis Vascular Access

医学 狭窄 血管成形术 支架 外科 危险系数 置信区间 气球 靶病变 透析 血管造影 随机对照试验 放射科 内科学 经皮冠状动脉介入治疗 心肌梗塞
作者
Mu‐Yang Hsieh,Pei-Shan Lin,Min‐Tsun Liao,Lin Lin,Tsung-Yan Chen,J.M. Boon,Ten-Fang Yang,Chih‐Cheng Wu
出处
期刊:European Journal of Vascular and Endovascular Surgery [Elsevier BV]
卷期号:66 (2): 253-260 被引量:3
标识
DOI:10.1016/j.ejvs.2023.05.028
摘要

Previous studies on arteriovenous fistulas have demonstrated the potential benefit of drug coated balloons (DCBs) in maintaining the patency of dialysis access. However, stenoses involving stent grafts were excluded from these studies. Therefore, the aim was to evaluate the effectiveness of DCBs in treating stent graft stenosis.This was a prospective, single blinded, randomised controlled study. From March 2017 to April 2021, 40 patients with dysfunctional vascular access owing to stent graft stenosis were randomised to treatment with a DCB or conventional balloon. Clinical follow up was scheduled at one, three, and six months, and angiographic follow up was performed six months after the intervention. The primary outcome was angiographic late luminal loss at six months, and secondary outcomes included target lesion and access circuit primary patency at six months.Thirty-six participants completed follow up angiography. The DCB group had a superior mean late luminal loss at six months compared with the control group (1.82 mm ± 1.83 mm vs. 3.63 mm ± 1.08 mm, respectively, p = .001). All 40 patients completed clinical follow up. The DCB group had a superior six month target lesion primary patency compared with the control group [hazard ratio (HR) 0.23, 95% confidence interval (CI) 0.07 - 0.71; p = .005). Additionally, the DCB group had a numerically higher six month access circuit primary patency rate than the control group, although the difference was not statistically significant (HR 0.54, 95% CI 0.26 - 1.11, p = .095).Conventional balloon angioplasty is not durable in stent graft stenosis treatment. Treatment with DCBs provides less angiographic late luminal loss and potentially superior primary patency of the target lesion than treatment with conventional balloons. [ClinicalTrials ID: NCT03360279.].
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
leeom发布了新的文献求助10
1秒前
Timo干物类完成签到,获得积分10
1秒前
北冥有鱼给北冥有鱼的求助进行了留言
1秒前
1秒前
王冉冉发布了新的文献求助30
1秒前
Ava应助易拉罐采纳,获得10
2秒前
隐形曼青应助无心的土豆采纳,获得10
2秒前
乐于助人大好人完成签到 ,获得积分10
2秒前
ZZQ完成签到,获得积分10
6秒前
量子星尘发布了新的文献求助10
6秒前
Lina HE完成签到 ,获得积分10
6秒前
852应助科研通管家采纳,获得10
6秒前
Ava应助科研通管家采纳,获得10
7秒前
ED应助科研通管家采纳,获得10
7秒前
领导范儿应助科研通管家采纳,获得10
7秒前
7秒前
Akim应助科研通管家采纳,获得10
7秒前
进步完成签到,获得积分10
7秒前
852应助科研通管家采纳,获得10
7秒前
ED应助科研通管家采纳,获得10
7秒前
英俊的铭应助科研通管家采纳,获得10
7秒前
SciGPT应助科研通管家采纳,获得10
7秒前
Akim应助科研通管家采纳,获得10
7秒前
iNk应助dh采纳,获得20
7秒前
orixero应助科研通管家采纳,获得30
7秒前
思源应助科研通管家采纳,获得10
7秒前
wanci应助科研通管家采纳,获得10
7秒前
赘婿应助科研通管家采纳,获得10
8秒前
wanci应助科研通管家采纳,获得10
8秒前
李健应助科研通管家采纳,获得10
8秒前
8秒前
8秒前
wanci应助科研通管家采纳,获得10
8秒前
8秒前
8秒前
8秒前
8秒前
科研通AI2S应助科研通管家采纳,获得10
8秒前
8秒前
隐形曼青应助科研通管家采纳,获得10
8秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038569
求助须知:如何正确求助?哪些是违规求助? 3576279
关于积分的说明 11374944
捐赠科研通 3305979
什么是DOI,文献DOI怎么找? 1819354
邀请新用户注册赠送积分活动 892698
科研通“疑难数据库(出版商)”最低求助积分说明 815048